Survivorship data in Prostate Cancer: Where are we and where do we need to be?

Beth  Russell; Katharina Beyer; Ailbhe Lawlor; Monique J Roobol; Lionne D.F.  Venderbos; Sebastiaan Remmers; Erik Briers; Sara J. MacLennan; Steven MacLennan; Muhammad Imran Omar; Mieke Van Hemelrijck; PIONEER Consortium

doi:10.1016/j.euros.2023.11.004

Survivorship data in Prostate Cancer: Where are we and where do we need to be?

Beth Russell^* (Corresponding Author), Katharina Beyer, Ailbhe Lawlor, Monique J Roobol, Lionne D.F. Venderbos, Sebastiaan Remmers, Erik Briers, Sara J. MacLennan, Steven MacLennan, Muhammad Imran Omar, Mieke Van Hemelrijck, PIONEER Consortium

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate › peer-review

4 Downloads (Pure)

Abstract

Cancer survivorship was recently identified as a research priority within prostate cancer (PCa) by PIONEER, a European network of excellence for big data in prostate cancer. Despite being a research priority, cancer survivorship lacks a clear and agreed definition, and there is a distinct paucity of patient-reported outcome (PRO) data available on the subject. Data collection on cancer survivorship depends on the availability and implementation of (validated), routinely collected patient-reported outcome measures (PROMs). There have been advancements in recent years in the existence of such PROMs. For instance, the European Organisation for Research and Treatment of Cancer Quality of Life Group (EORTC QLG) is undertaking the development of survivorship questionnaires. This provides an excellent start in the journey towards improving the data available on cancer survivorship. However, to further improve this, we propose that an agreed, standardised definition of (prostate) cancer survivorship must first be forged. Only then can real-world data on survivorship be collected to strengthen our knowledge base. With more men surviving their PCa than ever, this type of research is imperative to ensure the quality of life of these men is considered as much as their quantity of life

Original language	English
Pages (from-to)	27-29
Number of pages	3
Journal	European Urology Open Science
Volume	59
Early online date	19 Dec 2023
DOIs	https://doi.org/10.1016/j.euros.2023.11.004
Publication status	Published - Jan 2024

Bibliographical note

Funding/Support and role of the sponsor: PIONEER is funded through the IMI2 Joint Undertaking and is listed under grant agreement 777492. IMI2 receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The funding bodies played no direct role in this study. The views communicated here are those of PIONEER. Neither the IMI nor the European Union, EFPIA, or any associated partners are responsible for any use that may be made of the information contained herein.

Keywords

Cancer survivorship
prostate cancer
quality of life
PROMS

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.euros.2023.11.004Licence: CC BY

Russell_etal_EUOS_Survivorship_Data_Prostate_VOR
Under a Creative Commons license https://creativecommons.org/licenses/by/4.0/
Final published version, 272 KBLicence: CC BY

Cite this

@article{1a6c12b6fd0b455784cb9592d159d527,

title = "Survivorship data in Prostate Cancer: Where are we and where do we need to be?",

abstract = "Cancer survivorship was recently identified as a research priority within prostate cancer (PCa) by PIONEER, a European network of excellence for big data in prostate cancer. Despite being a research priority, cancer survivorship lacks a clear and agreed definition, and there is a distinct paucity of patient-reported outcome (PRO) data available on the subject. Data collection on cancer survivorship depends on the availability and implementation of (validated), routinely collected patient-reported outcome measures (PROMs). There have been advancements in recent years in the existence of such PROMs. For instance, the European Organisation for Research and Treatment of Cancer Quality of Life Group (EORTC QLG) is undertaking the development of survivorship questionnaires. This provides an excellent start in the journey towards improving the data available on cancer survivorship. However, to further improve this, we propose that an agreed, standardised definition of (prostate) cancer survivorship must first be forged. Only then can real-world data on survivorship be collected to strengthen our knowledge base. With more men surviving their PCa than ever, this type of research is imperative to ensure the quality of life of these men is considered as much as their quantity of life",

keywords = "Cancer survivorship, prostate cancer, quality of life, PROMS",

author = "Beth Russell and Katharina Beyer and Ailbhe Lawlor and Roobol, {Monique J} and Venderbos, {Lionne D.F.} and Sebastiaan Remmers and Erik Briers and MacLennan, {Sara J.} and Steven MacLennan and Omar, {Muhammad Imran} and {Van Hemelrijck}, Mieke and {PIONEER Consortium}",

note = "Funding/Support and role of the sponsor: PIONEER is funded through the IMI2 Joint Undertaking and is listed under grant agreement 777492. IMI2 receives support from the European Union{\textquoteright}s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The funding bodies played no direct role in this study. The views communicated here are those of PIONEER. Neither the IMI nor the European Union, EFPIA, or any associated partners are responsible for any use that may be made of the information contained herein. ",

year = "2024",

month = jan,

doi = "10.1016/j.euros.2023.11.004",

language = "English",

volume = "59",

pages = "27--29",

journal = "European Urology Open Science",

issn = "2666-1683",

publisher = "Elsevier",

}

TY - JOUR

T1 - Survivorship data in Prostate Cancer

T2 - Where are we and where do we need to be?

AU - Russell, Beth

AU - Beyer, Katharina

AU - Lawlor, Ailbhe

AU - Roobol, Monique J

AU - Venderbos, Lionne D.F.

AU - Remmers, Sebastiaan

AU - Briers, Erik

AU - MacLennan, Sara J.

AU - MacLennan, Steven

AU - Omar, Muhammad Imran

AU - Van Hemelrijck, Mieke

AU - PIONEER Consortium

N1 - Funding/Support and role of the sponsor: PIONEER is funded through the IMI2 Joint Undertaking and is listed under grant agreement 777492. IMI2 receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The funding bodies played no direct role in this study. The views communicated here are those of PIONEER. Neither the IMI nor the European Union, EFPIA, or any associated partners are responsible for any use that may be made of the information contained herein.

PY - 2024/1

Y1 - 2024/1

N2 - Cancer survivorship was recently identified as a research priority within prostate cancer (PCa) by PIONEER, a European network of excellence for big data in prostate cancer. Despite being a research priority, cancer survivorship lacks a clear and agreed definition, and there is a distinct paucity of patient-reported outcome (PRO) data available on the subject. Data collection on cancer survivorship depends on the availability and implementation of (validated), routinely collected patient-reported outcome measures (PROMs). There have been advancements in recent years in the existence of such PROMs. For instance, the European Organisation for Research and Treatment of Cancer Quality of Life Group (EORTC QLG) is undertaking the development of survivorship questionnaires. This provides an excellent start in the journey towards improving the data available on cancer survivorship. However, to further improve this, we propose that an agreed, standardised definition of (prostate) cancer survivorship must first be forged. Only then can real-world data on survivorship be collected to strengthen our knowledge base. With more men surviving their PCa than ever, this type of research is imperative to ensure the quality of life of these men is considered as much as their quantity of life

AB - Cancer survivorship was recently identified as a research priority within prostate cancer (PCa) by PIONEER, a European network of excellence for big data in prostate cancer. Despite being a research priority, cancer survivorship lacks a clear and agreed definition, and there is a distinct paucity of patient-reported outcome (PRO) data available on the subject. Data collection on cancer survivorship depends on the availability and implementation of (validated), routinely collected patient-reported outcome measures (PROMs). There have been advancements in recent years in the existence of such PROMs. For instance, the European Organisation for Research and Treatment of Cancer Quality of Life Group (EORTC QLG) is undertaking the development of survivorship questionnaires. This provides an excellent start in the journey towards improving the data available on cancer survivorship. However, to further improve this, we propose that an agreed, standardised definition of (prostate) cancer survivorship must first be forged. Only then can real-world data on survivorship be collected to strengthen our knowledge base. With more men surviving their PCa than ever, this type of research is imperative to ensure the quality of life of these men is considered as much as their quantity of life

KW - Cancer survivorship

KW - prostate cancer

KW - quality of life

KW - PROMS

U2 - 10.1016/j.euros.2023.11.004

DO - 10.1016/j.euros.2023.11.004

M3 - Comment/debate

C2 - 38298764

SN - 2666-1683

VL - 59

SP - 27

EP - 29

JO - European Urology Open Science

JF - European Urology Open Science

ER -

Survivorship data in Prostate Cancer: Where are we and where do we need to be?

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this